United States · FDA National Drug Code directory
Dexmedetomidine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 36000-262_29fe8860-4376-4fe2-ab33-e008e94ddd67
- Product NDC
- 36000-262
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- dexmedetomidine hydrochloride
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260416
- Source listing expiry
- 20271231
Source-listed ingredients
- DEXMEDETOMIDINE HYDROCHLORIDE — 100 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 VIAL, SINGLE-DOSE in 1 CARTON (36000-262-05) / 2 mL in 1 VIAL, SINGLE-DOSE (36000-262-01) · 36000-262-05
- 10 VIAL, SINGLE-DOSE in 1 CARTON (36000-262-10) / 2 mL in 1 VIAL, SINGLE-DOSE (36000-262-01) · 36000-262-10
- 25 VIAL, SINGLE-DOSE in 1 CARTON (36000-262-25) / 2 mL in 1 VIAL, SINGLE-DOSE (36000-262-01) · 36000-262-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →